Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice

Neuropharmacology

Volumn 51, Issue 4, 2006, Pages 914-922

  Ago, Yukio ^a   Nakamura, Shigeo ^a   Uda, Misato ^a   Kajii, Yasushi ^b   Abe, Michikazu ^b   Baba, Akemichi ^a   Matsuda, Toshio ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT1A receptor; Locomotor activity; Methamphetamine (METH); Osemozotan; Sensitization; Serotonin (5 HT) release

Indexed keywords

DOPAMINE; METHAMPHETAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; OSEMOZOTAN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; BIOGENIC AMINE; CENTRAL STIMULANT AGENT; DIOXANE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG WITHDRAWAL; EXTRACELLULAR MATRIX; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; BRAIN LEVEL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG INTERACTION; ELECTROCHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; MOUSE STRAIN;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIOXANES; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTROCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; MICRODIALYSIS; MOTOR ACTIVITY; PIPERAZINES; PYRIDINES; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 33748632380     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.06.001     Document Type: Article

References (58)

1. Abe M., Tabata R., Saito K., Matsuda T., Baba A., and Egawa M. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. J. Pharmacol. Exp. Ther. 278 (1996) 898-905
2. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J. Neurochem. 83 (2002) 353-359
3. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
4. Ago Y., Nakamura S., Baba A., and Matsuda T. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30 (2005) 43-51
5. 1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?. J. Psychopharmacol. 15 (2001) 37-46
6. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
7. 1A syndrome. Pharmacol. Biochem. Behav. 57 (1997) 897-908
8. Bonhomme N., Cador M., Stinus L., Le Moal M., and Spampinato U. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res. 675 (1995) 215-223
9. 2 receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology 28 (2003) 1086-1095
10. Cole S.O. Brain mechanisms of amphetamine-induced anorexia, locomotion, and stereotypy: a review. Neurosci. Biobehav. Rev. 2 (1978) 89-100
11. Creese I., and Iversen S.D. The role of forebrain dopamine systems in amphetamine-induced stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Psychopharmacology 39 (1974) 345-357
12. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J.-P. α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J. Neurosci. 22 (2002) 2873-2884
13. Dulawa S.C., and Geyer M.A. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39 (2000) 2170-2179
14. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
15. 2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546 (1991) 40-46
16. 1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J. Neurochem. 76 (2001) 1521-1531
17. 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol. 287 (1995) 179-184
18. Iyo M., Bi Y., Hashimoto K., Inada T., and Fukui S. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur. J. Pharmacol. 312 (1996) 163-170
19. 2-adrenoceptor antagonist atipamezole reduces the development and expression of D-amphetamine-induced behavioural sensitization. Naunyn-Schmiedebergs Arch. Pharmacol. 367 (2003) 274-280
20. Kalinski M.I., Dluzen D.E., and Stadulis R. Methamphetamine produces subsequent reductions in running time to exhaustion in mice. Brain Res. 921 (2001) 160-164
21. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16 (1991) 223-244
22. 1A receptor knockout mice. Psychopharmacology 159 (2002) 407-414
23. Kitanaka N., Kitanaka J., and Takemura M. Chronic methamphetamine administration reduces histamine-stimulated phosphoinositide hydrolysis in mouse frontal cortex. Biochem. Biophys. Res. Commun. 300 (2003) 932-937
24. Kubota Y., Ito C., Sakurai E., Watanabe T., and Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J. Neurochem. 83 (2002) 837-845
25. Kuczenski R., Segal D.S., and Todd P.K. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134 (1997) 221-229
26. 1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice. Pharmacol. Biochem. Behav. 52 (1995) 759-763
27. Kuribara H., Yasuda H., and Uchihashi Y. Age-dependent induction and maintenance of sensitization to methamphetamine-induced hyperactivity in mice. Psychiatry Clin. Neurosci. 50 (1996) 299-303
28. 1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex. Brain Res. 743 (1996) 357-361
29. Kuroki T., Meltzer H.Y., and Ichikawa J. Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J. Pharmacol. Exp. Ther. 288 (1999) 774-781
30. 1A receptors. Jpn. J. Pharmacol. 69 (1995) 357-366
31. Nakamura S., Ago Y., Itoh S., Koyama Y., Baba A., and Matsuda T. Effect of zotepine on dopamine, serotonin and noradrenaline release in the prefrontal cortex. Eur. J. Pharmacol. 528 (2005) 95-98
32. Narita M., Akai H., Nagumo Y., Sunagawa N., Hasebe K., Nagase H., Kita T., Hara C., and Suzuki T. Implication of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127 (2004) 941-948
33. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nature Rev. Neurosci. 2 (2001) 119-128
34. Patrick S.L., Thompson T.L., Walker J.M., and Patrick R.L. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538 (1991) 343-346
35. Paulson P.E., and Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19 (1995) 56-65
36. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346 (1985) 205-230
37. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25 (1997) 192-216
38. 1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav. Pharmacol. 8 (1997) 699-706
39. 1A receptors inhibits amphetamine sensitization in mice. Life Sci. 66 (2000) 1011-1019
40. 1B receptors in the sensitization to amphetamine in mice. Eur. J. Pharmacol. 422 (2001) 91-99
41. Rigdon G.C., and Weatherspoon J.K. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J. Pharmacol. Exp. Ther. 263 (1992) 486-493
42. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11 (1986) 157-198
43. Robinson T.E., Jurson P.A., Bennett J.A., and Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462 (1988) 211-222
44. Roughan J.V., and Flecknell P.A. Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab. Animal 36 (2002) 322-343
45. 1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170 (2003) 73-79
46. Schoffelmeer A.N., De Vries T.J., Wardeh G., van de Ven H.W., and Vanderschuren L.J. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J. Neurosci. 22 (2002) 3269-3276
47. Segal D.S., and Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571 (1992) 330-337
48. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 639-677
49. Sipes T.A., and Geyer M.A. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117 (1995) 41-48
50. Sripada S., Gaytan O., Swann A., and Dafny N. The role of MK-801 in sensitization to stimulants. Brain Res. Rev. 35 (2001) 97-114
51. Stephans S.E., and Yamamoto B.Y. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 700 (1995) 99-106
52. Tirelli E., Laviola G., and Adriani W. Ontogenesis of behavioral sensitization and conditioned place preference induced by psychostimulants in laboratory rodents. Neurosci. Biobehav. Rev. 27 (2003) 163-178
53. Tsuchida K., Ujike H., Kanzaki A., Fujiwara Y., and Akiyama K. Ontogeny of enhanced striatal dopamine release in rats with methamphetamine-induced behavioral sensitization. Pharmacol. Biochem. Behav. 47 (1994) 161-169
54. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16 (1996) 2411-2420
55. Vezina P., and Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499 (1989) 108-120
56. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54 (1998) 679-720
57. Wolf M.E., White F.J., Nassar R., Brooderson R.J., and Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264 (1993) 249-255
58. Xu M., Guo Y., Vorhees C.V., and Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res. 852 (2000) 198-207